$1.02 Billion is the total value of SPHERA FUNDS MANAGEMENT LTD.'s 133 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 63.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | ISHARES TRput | $173,118,000 | +74.0% | 13,865 | +73.3% | 16.96% | +63.7% | |
| AGN | New | ALLERGAN PLC | $53,743,000 | – | 177,100 | +100.0% | 5.26% | – |
| Buy | SPDR SERIES TRUSTput | $50,448,000 | +52.6% | 2,000 | +33.3% | 4.94% | +43.6% | |
| Buy | TEVA PHARMACEUTICAL INDS LTDcall | $38,415,000 | +76.2% | 6,500 | +85.7% | 3.76% | +65.8% | |
| GILD | GILEAD SCIENCES INC | $37,466,000 | +19.3% | 320,000 | 0.0% | 3.67% | +12.3% | |
| PFE | Sell | PFIZER INC | $29,306,000 | -17.7% | 874,013 | -14.6% | 2.87% | -22.6% |
| Buy | ISHARES TRput | $27,673,000 | +168.6% | 750 | +150.0% | 2.71% | +152.7% | |
| ABBV | ABBVIE INC | $27,346,000 | +14.8% | 407,000 | 0.0% | 2.68% | +8.0% | |
| BIIB | Buy | BIOGEN INC | $24,531,000 | +481.0% | 60,730 | +507.3% | 2.40% | +446.1% |
| MRK | Buy | MERCK & CO INC NEW | $22,772,000 | +5.6% | 400,000 | +6.7% | 2.23% | -0.6% |
| Buy | SELECT SECTOR SPDR TRput | $22,317,000 | +136.8% | 3,000 | +130.8% | 2.19% | +122.8% | |
| CELG | Buy | CELGENE CORP | $18,518,000 | +129.5% | 160,000 | +128.6% | 1.81% | +116.0% |
| New | PERRIGO CO PLCcall | $18,483,000 | – | 1,000 | +100.0% | 1.81% | – | |
| New | BIOMARIN PHARMACEUTICAL INCcall | $13,678,000 | – | 1,000 | +100.0% | 1.34% | – | |
| MYL | Sell | MYLAN N V | $11,876,000 | -26.5% | 175,000 | -35.7% | 1.16% | -30.8% |
| ORA | ORMAT TECHNOLOGIES INC | $11,309,000 | -6.2% | 80,092 | 0.0% | 1.11% | -11.7% | |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $10,546,000 | +26.3% | 120,000 | +6.7% | 1.03% | +18.9% |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDadr | $10,478,000 | -58.2% | 177,300 | -56.0% | 1.03% | -60.7% |
| VRX | VALEANT PHARMACEUTICALS INTL | $10,163,000 | +11.8% | 45,750 | 0.0% | 1.00% | +5.2% | |
| NVS | NOVARTIS A Gsponsored adr | $9,834,000 | -0.3% | 100,000 | 0.0% | 0.96% | -6.2% | |
| AMGN | Sell | AMGEN INC | $9,242,000 | -51.9% | 60,200 | -49.9% | 0.90% | -54.8% |
| CXRX | New | CONCORDIA HEALTHCARE CORP | $9,025,000 | – | 100,000 | +100.0% | 0.88% | – |
| VRNT | Buy | VERINT SYS INC | $8,470,000 | +11.8% | 139,434 | +14.0% | 0.83% | +5.2% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $8,207,000 | -17.7% | 60,000 | -25.0% | 0.80% | -22.5% |
| CHKP | Buy | CHECK POINT SOFTWARE TECH LTord | $7,246,000 | +22.9% | 91,087 | +26.6% | 0.71% | +15.6% |
| SHPG | SHIRE PLCsponsored adr | $6,866,000 | -5.0% | 134,751 | 0.0% | 0.67% | -10.6% | |
| SGEN | Sell | SEATTLE GENETICS INC | $6,776,000 | -4.2% | 140,000 | -30.0% | 0.66% | -9.8% |
| BMY | BRISTOL MYERS SQUIBB CO | $6,654,000 | +3.2% | 100,000 | 0.0% | 0.65% | -3.0% | |
| ALDR | Sell | ALDER BIOPHARMACEUTICALS INC | $6,621,000 | +52.9% | 125,000 | -16.7% | 0.65% | +43.9% |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $6,515,000 | +28.9% | 513,390 | -5.5% | 0.64% | +21.3% |
| BCOMF | New | B COMMUNICATIONS LTD | $6,448,000 | – | 5,977,000 | +100.0% | 0.63% | – |
| FOLD | AMICUS THERAPEUTICS INC | $6,368,000 | +30.1% | 450,000 | 0.0% | 0.62% | +22.4% | |
| AMAG | Sell | AMAG PHARMACEUTICALS INC | $6,231,000 | -43.1% | 90,230 | -54.9% | 0.61% | -46.4% |
| PRTA | Buy | PROTHENA CORP PLC | $6,064,000 | +80.4% | 115,133 | +30.6% | 0.59% | +69.7% |
| ARRY | Sell | ARRAY BIOPHARMA INC | $5,768,000 | -15.3% | 800,000 | -13.4% | 0.56% | -20.3% |
| FWP | Sell | FORWARD PHARMA A/Ssponsored adr | $5,708,000 | +12.0% | 150,000 | -16.7% | 0.56% | +5.3% |
| EWG | Buy | ISHARESmsci germany etf | $5,371,000 | +66.6% | 192,630 | +78.4% | 0.53% | +56.5% |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $5,344,000 | +67.5% | 43,500 | +24.3% | 0.52% | +57.5% |
| CYNA | New | CYNAPSUS THERAPEUTICS INC | $5,324,000 | – | 316,448 | +100.0% | 0.52% | – |
| INSM | Sell | INSMED INC | $5,250,000 | +1.0% | 215,000 | -14.0% | 0.51% | -5.0% |
| TSRO | New | TESARO INC | $5,144,000 | – | 87,500 | +100.0% | 0.50% | – |
| MDCO | Buy | MEDICINES CO | $5,150,000 | +83.8% | 180,000 | +80.0% | 0.50% | +72.6% |
| CATB | New | CATABASIS PHARMACEUTICALS IN | $5,060,000 | – | 446,036 | +100.0% | 0.50% | – |
| UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $5,017,000 | -40.4% | 28,840 | -41.0% | 0.49% | -44.0% |
| ACOR | New | ACORDA THERAPEUTICS INC | $5,000,000 | – | 150,000 | +100.0% | 0.49% | – |
| CPRX | Buy | CATALYST PHARMACEUTICALS INC | $4,956,000 | +4.1% | 1,200,000 | +9.1% | 0.48% | -2.2% |
| BLCM | Sell | BELLICUM PHARMACEUTICALS INC | $4,924,000 | -13.5% | 231,514 | -7.2% | 0.48% | -18.7% |
| RARE | New | ULTRAGENYX PHARMACEUTICAL IN | $4,884,000 | – | 47,700 | +100.0% | 0.48% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $4,565,000 | – | 150,000 | +100.0% | 0.45% | – |
| 3106PS | New | DELPHI AUTOMOTIVE PLC | $4,516,000 | – | 53,070 | +100.0% | 0.44% | – |
| ORBK | Buy | ORBOTECH LTDord | $4,470,000 | +41.8% | 214,922 | +9.3% | 0.44% | +33.5% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $4,435,000 | – | 37,000 | +100.0% | 0.43% | – |
| RLYP | Sell | RELYPSA INC | $4,368,000 | -10.3% | 132,000 | -2.2% | 0.43% | -15.6% |
| KMPH | New | KEMPHARM INC | $4,363,000 | – | 237,500 | +100.0% | 0.43% | – |
| ICPT | Buy | INTERCEPT PHARMACEUTICALS IN | $4,224,000 | -0.1% | 17,500 | +16.7% | 0.41% | -5.9% |
| GNCA | Buy | GENOCEA BIOSCIENCES INC | $4,149,000 | +181.7% | 302,200 | +143.3% | 0.41% | +165.4% |
| ITCI | Sell | INTRA CELLULAR THERAPIES INC | $4,090,000 | +14.2% | 128,000 | -14.7% | 0.40% | +7.5% |
| BITI | New | BIOTIE THERAPIES OYJsponsored adr | $3,930,000 | – | 196,800 | +100.0% | 0.38% | – |
| FEZ | Buy | SPDR INDEX SHS FDSeuro stoxx 50 | $3,927,000 | +7.6% | 104,920 | +11.6% | 0.38% | +1.3% |
| PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $3,917,000 | +3.2% | 86,000 | -14.0% | 0.38% | -2.8% |
| FOMX | Buy | FOAMIX PHARMACEUTICALS LTD | $3,895,000 | +110.5% | 380,000 | +90.0% | 0.38% | +97.9% |
| MDVN | Sell | MEDIVATION INC | $3,896,000 | -16.4% | 34,115 | -5.5% | 0.38% | -21.2% |
| DEPO | Sell | DEPOMED INC | $3,863,000 | -13.8% | 180,000 | -10.0% | 0.38% | -19.1% |
| NVLS | New | NIVALIS THERAPEUTICS INC | $3,863,000 | – | 255,000 | +100.0% | 0.38% | – |
| RCPT | Buy | RECEPTOS INC | $3,801,000 | +31.7% | 20,000 | +14.3% | 0.37% | +24.0% |
| SNSS | Sell | SUNESIS PHARMACEUTICALS INC | $3,717,000 | +16.7% | 1,235,000 | -5.0% | 0.36% | +9.6% |
| LIFE | New | ATYR PHARMA INC | $3,696,000 | – | 209,027 | +100.0% | 0.36% | – |
| AOS | Sell | SMITH A O | $3,644,000 | -9.9% | 50,620 | -17.8% | 0.36% | -15.2% |
| KRE | New | SPDR SERIES TRUSTs&p regl bkg | $3,536,000 | – | 80,080 | +100.0% | 0.35% | – |
| DVAX | New | DYNAVAX TECHNOLOGIES CORP | $3,514,000 | – | 150,000 | +100.0% | 0.34% | – |
| SAGE | Sell | SAGE THERAPEUTICS INC | $3,504,000 | +6.1% | 48,000 | -27.0% | 0.34% | -0.3% |
| KITE | Sell | KITE PHARMA INC | $3,473,000 | -8.7% | 56,970 | -13.6% | 0.34% | -14.1% |
| MRNS | Buy | MARINUS PHARMACEUTICALS INC | $3,463,000 | +80.4% | 298,533 | +39.8% | 0.34% | +69.5% |
| ARWR | New | ARROWHEAD RESH CORP | $3,396,000 | – | 475,000 | +100.0% | 0.33% | – |
| HALO | New | HALOZYME THERAPEUTICS INC | $3,387,000 | – | 150,000 | +100.0% | 0.33% | – |
| OCUL | New | OCULAR THERAPEUTIX INC | $3,365,000 | – | 160,000 | +100.0% | 0.33% | – |
| PIRS | New | PIERIS PHARMACEUTICALS INC | $3,300,000 | – | 1,200,000 | +100.0% | 0.32% | – |
| RPTP | New | RAPTOR PHARMACEUTICAL CORP | $3,261,000 | – | 206,500 | +100.0% | 0.32% | – |
| TXMD | Buy | THERAPEUTICSMD INC | $3,242,000 | +46.8% | 412,500 | +13.0% | 0.32% | +38.3% |
| MGNX | Buy | MACROGENICS INC | $3,227,000 | +71.5% | 85,000 | +41.7% | 0.32% | +61.2% |
| PTCT | Sell | PTC THERAPEUTICS INC | $3,201,000 | -24.9% | 66,500 | -5.0% | 0.31% | -29.3% |
| Buy | TRILLIUM THERAPEUTICS INC | $3,208,000 | +66.9% | 147,000 | +54.7% | 0.31% | +57.0% | |
| XLRN | New | ACCELERON PHARMA INC | $3,164,000 | – | 100,000 | +100.0% | 0.31% | – |
| PAY | Buy | VERIFONE SYS INC | $3,160,000 | +19.9% | 93,055 | +23.2% | 0.31% | +13.1% |
| QURE | Buy | UNIQURE NV | $3,105,000 | +24.6% | 115,000 | +12.3% | 0.30% | +17.4% |
| FPRX | New | FIVE PRIME THERAPEUTICS INC | $3,105,000 | – | 125,000 | +100.0% | 0.30% | – |
| AGTC | Sell | APPLIED GENETIC TECHNOL CORP | $3,070,000 | -34.7% | 200,124 | -14.9% | 0.30% | -38.4% |
| MLNX | New | MELLANOX TECHNOLOGIES LTD | $3,054,000 | – | 62,850 | +100.0% | 0.30% | – |
| TKMR | Sell | TEKMIRA PHARMACEUTICALS CORP | $3,024,000 | -42.0% | 255,000 | -14.6% | 0.30% | -45.5% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $2,990,000 | +2.0% | 95,000 | -5.0% | 0.29% | -3.9% |
| AAPL | Sell | APPLE INC | $2,913,000 | -45.2% | 23,223 | -45.7% | 0.28% | -48.6% |
| IMDZ | Buy | IMMUNE DESIGN CORP | $2,891,000 | +5.8% | 140,000 | +8.2% | 0.28% | -0.4% |
| PTC THERAPEUTICS INCcall | $2,888,000 | -20.9% | 600 | 0.0% | 0.28% | -25.5% | ||
| SBUX | Sell | STARBUCKS CORP | $2,873,000 | -30.5% | 53,583 | -38.6% | 0.28% | -34.7% |
| CBYL | New | CARBYLAN THERAPEUTICS INC | $2,860,000 | – | 400,000 | +100.0% | 0.28% | – |
| MEDICINES COcall | $2,861,000 | +2.1% | 1,000 | 0.0% | 0.28% | -4.1% | ||
| WIX | New | WIX COM LTD | $2,842,000 | – | 120,305 | +100.0% | 0.28% | – |
| CYTK | New | CYTOKINETICS INC | $2,838,000 | – | 422,250 | +100.0% | 0.28% | – |
| CLCD | New | COLUCID PHARMACEUTICALS INC | $2,824,000 | – | 317,250 | +100.0% | 0.28% | – |
| ISIS | New | ISIS PHARMACEUTICALS INC | $2,762,000 | – | 48,000 | +100.0% | 0.27% | – |
| SCYX | New | SCYNEXIS INC | $2,751,000 | – | 313,000 | +100.0% | 0.27% | – |
| OTIC | Buy | OTONOMY INC | $2,598,000 | +5.0% | 113,000 | +61.4% | 0.25% | -1.6% |
| TRVN | Buy | TREVENA INC | $2,567,000 | +0.5% | 410,000 | +4.6% | 0.25% | -5.6% |
| ELLO | Buy | ELLOMAY CAPITAL LIMITED | $2,518,000 | +33.7% | 246,697 | +11.3% | 0.25% | +26.0% |
| SNA | SNAP ON INC | $2,443,000 | +8.3% | 15,340 | 0.0% | 0.24% | +1.7% | |
| TBRA | New | TOBIRA THERAPEUTICS INC | $2,374,000 | – | 137,622 | +100.0% | 0.23% | – |
| TTPH | Sell | TETRAPHASE PHARMACEUTICALS I | $2,348,000 | -14.6% | 49,500 | -34.0% | 0.23% | -19.6% |
| SMMT | Buy | SUMMIT THERAPEUTICS PLCspons ads | $2,280,000 | +5.2% | 205,200 | +17.3% | 0.22% | -1.3% |
| PTN | Buy | PALATIN TECHNOLOGIES INC | $2,261,000 | +113.1% | 2,540,266 | +144.2% | 0.22% | +100.9% |
| WAB | Buy | WABTEC CORP | $2,108,000 | +3.2% | 22,365 | +4.0% | 0.21% | -3.3% |
| ALDX | Buy | ALDEYRA THERAPEUTICS INC | $2,056,000 | +72.2% | 265,000 | +130.4% | 0.20% | +62.1% |
| ITEK | Sell | INOTEK PHARMACEUTICALS CORP | $1,862,000 | -14.1% | 380,000 | -5.0% | 0.18% | -19.5% |
| CHTR | New | CHARTER COMMUNICATIONS INC Dcl a new | $1,724,000 | – | 10,065 | +100.0% | 0.17% | – |
| TW | Sell | TOWERS WATSON & COcl a | $1,611,000 | -68.2% | 12,807 | -66.6% | 0.16% | -70.0% |
| EXEL | Sell | EXELIXIS INC | $1,504,000 | +17.0% | 400,000 | -20.0% | 0.15% | +9.7% |
| New | APTOSE BIOSCIENCES INC | $1,415,000 | – | 221,096 | +100.0% | 0.14% | – | |
| BRCM | Sell | BROADCOM CORPcl a | $1,282,000 | -70.6% | 24,894 | -75.3% | 0.13% | -72.2% |
| VFC | Sell | V F CORP | $1,227,000 | -61.4% | 17,600 | -58.3% | 0.12% | -63.7% |
| NICE | New | NICE SYS LTDsponsored adr | $1,161,000 | – | 18,250 | +100.0% | 0.11% | – |
| IMMU | Sell | IMMUNOMEDICS INC | $995,000 | -13.4% | 245,000 | -18.3% | 0.10% | -19.2% |
| GNVC | Sell | GENVEC INC | $735,000 | -52.9% | 360,325 | -31.8% | 0.07% | -55.6% |
| IPXL | Sell | IMPAX LABORATORIES INC | $689,000 | -85.3% | 15,000 | -85.0% | 0.07% | -86.3% |
| SPNS | SAPIENS INTL CORP N V | $586,000 | +26.6% | 56,420 | 0.0% | 0.06% | +18.8% | |
| CARA | New | CARA THERAPEUTICS INC | $567,000 | – | 46,700 | +100.0% | 0.06% | – |
| GALT | Sell | GALECTIN THERAPEUTICS INC | $560,000 | -62.9% | 205,000 | -54.4% | 0.06% | -65.0% |
| ZSAN | Sell | ZOSANO PHARMA CORP | $452,000 | -75.8% | 62,300 | -66.3% | 0.04% | -77.3% |
| EARS | Sell | AURIS MED HLDG AG | $316,000 | -68.3% | 63,967 | -65.7% | 0.03% | -70.2% |
| PRGO | Sell | PERRIGO CO PLC | $246,000 | -91.9% | 273 | -98.5% | 0.02% | -92.4% |
| CNCE | Sell | CONCERT PHARMACEUTICALS INC | $236,000 | -95.8% | 15,858 | -95.8% | 0.02% | -96.1% |
| TTHI | Sell | TRANSITION THERAPEUTICS INC | $148,000 | -92.1% | 70,273 | -74.3% | 0.01% | -92.8% |
| ADHD | Exit | ALCOBRA LTD | $0 | – | -200 | -100.0% | 0.00% | – |
| LMNS | LUMENIS LTD | $0 | – | 245 | 0.0% | 0.00% | – | |
| SPPI | Exit | SPECTRUM PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.03% | – |
| BLRX | Exit | BIOLINERX LTDsponsored adr | $0 | – | -193,284 | -100.0% | -0.04% | – |
| OHRP | Exit | OHR PHARMACEUTICAL INC | $0 | – | -187,500 | -100.0% | -0.05% | – |
| ACHN | Exit | ACHILLION PHARMACEUTICALS IN | $0 | – | -65,538 | -100.0% | -0.07% | – |
| MSTX | Exit | MAST THERAPEUTICS INC | $0 | – | -1,374,900 | -100.0% | -0.07% | – |
| EBIO | Exit | ELEVEN BIOTHERAPEUTICS INC | $0 | – | -87,110 | -100.0% | -0.08% | – |
| JUNO | Exit | JUNO THERAPEUTICS INC | $0 | – | -15,000 | -100.0% | -0.10% | – |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -157,179 | -100.0% | -0.11% | – |
| SGNT | Exit | SAGENT PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.12% | – |
| HRTX | Exit | HERON THERAPEUTICS INC | $0 | – | -79,900 | -100.0% | -0.12% | – |
| STML | Exit | STEMLINE THERAPEUTICS INC | $0 | – | -80,957 | -100.0% | -0.12% | – |
| ASND | Exit | ASCENDIS PHARMA A Ssponsored adr | $0 | – | -70,000 | -100.0% | -0.13% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -100,000 | -100.0% | -0.14% | – |
| NLNK | Exit | NEWLINK GENETICS CORP | $0 | – | -25,000 | -100.0% | -0.14% | – |
| MDGN | Exit | MEDGENICS INC | $0 | – | -175,000 | -100.0% | -0.15% | – |
| OCRX | Exit | OCERA THERAPEUTICS INC | $0 | – | -321,254 | -100.0% | -0.16% | – |
| Exit | MANNKIND CORPput | $0 | – | -3,000 | -100.0% | -0.16% | – | |
| CNAT | Exit | CONATUS PHARMACEUTICALS INC | $0 | – | -220,000 | -100.0% | -0.16% | – |
| TKAI | Exit | TOKAI PHARMACEUTICALS INC | $0 | – | -146,341 | -100.0% | -0.17% | – |
| CLLS | Exit | CELLECTIS S Asponsored ads | $0 | – | -50,000 | -100.0% | -0.18% | – |
| THRM | Exit | GENTHERM INC | $0 | – | -34,550 | -100.0% | -0.18% | – |
| UNP | Exit | UNION PAC CORP | $0 | – | -17,489 | -100.0% | -0.20% | – |
| SRCL | Exit | STERICYCLE INC | $0 | – | -14,500 | -100.0% | -0.21% | – |
| PCLN | Exit | PRICELINE GRP INC | $0 | – | -1,820 | -100.0% | -0.22% | – |
| ITB | Exit | ISHARESus home cons etf | $0 | – | -76,000 | -100.0% | -0.22% | – |
| SGMO | Exit | SANGAMO BIOSCIENCES INC | $0 | – | -140,000 | -100.0% | -0.23% | – |
| AAVL | Exit | AVALANCHE BIOTECHNOLOGIES IN | $0 | – | -60,000 | -100.0% | -0.25% | – |
| ATRA | Exit | ATARA BIOTHERAPEUTICS INC | $0 | – | -63,579 | -100.0% | -0.28% | – |
| RTRX | Exit | RETROPHIN INC | $0 | – | -111,392 | -100.0% | -0.28% | – |
| EPZM | Exit | EPIZYME INC | $0 | – | -150,000 | -100.0% | -0.29% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -90,000 | -100.0% | -0.29% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -105,000 | -100.0% | -0.30% | – |
| KERX | Exit | KERYX BIOPHARMACEUTICALS INC | $0 | – | -230,000 | -100.0% | -0.30% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -75,000 | -100.0% | -0.31% | – |
| AEGR | Exit | AEGERION PHARMACEUTICALS INC | $0 | – | -120,000 | -100.0% | -0.33% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -13,796 | -100.0% | -0.34% | – |
| TJX | Exit | TJX COS INC NEW | $0 | – | -47,330 | -100.0% | -0.34% | – |
| ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -36,000 | -100.0% | -0.35% | – |
| Exit | DYAX CORPput | $0 | – | -2,000 | -100.0% | -0.35% | – | |
| ARIA | Exit | ARIAD PHARMACEUTICALS INC | $0 | – | -445,000 | -100.0% | -0.38% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -25,000 | -100.0% | -0.45% | – |
| XLV | Exit | SELECT SECTOR SPDR TRsbi healthcare | $0 | – | -59,853 | -100.0% | -0.45% | – |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -42,260 | -100.0% | -0.45% | – |
| KYTH | Exit | KYTHERA BIOPHARMACEUTICALS I | $0 | – | -90,000 | -100.0% | -0.47% | – |
| KMDA | Exit | KAMADA LTD | $0 | – | -293,727 | -100.0% | -0.54% | – |
| INSYQ | Exit | INSYS THERAPEUTICS INC NEW | $0 | – | -100,000 | -100.0% | -0.60% | – |
| AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -86,637 | -100.0% | -0.62% | – |
| DYAX | Exit | DYAX CORP | $0 | – | -367,556 | -100.0% | -0.64% | – |
| IWM | Exit | ISHARES TRrussell 2000 etf | $0 | – | -56,100 | -100.0% | -0.73% | – |
| ASPX | Exit | AUSPEX PHARMACEUTICALS INC | $0 | – | -125,074 | -100.0% | -1.31% | – |
| ENDP | Exit | ENDO INTL PLC | $0 | – | -210,000 | -100.0% | -1.96% | – |
| B108PS | Exit | ACTAVIS PLC | $0 | – | -192,100 | -100.0% | -5.95% | – |
| Exit | SPDR S&P 500 ETF TRput | $0 | – | -3,500 | -100.0% | -7.52% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-06
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICAL-SP ADR | 36 | Q3 2023 | 8.4% |
| MERCK & CO INC NEW | 35 | Q3 2023 | 8.4% |
| NICE Systems Ltd | 27 | Q3 2023 | 4.4% |
| BIOGEN INC | 26 | Q3 2023 | 6.7% |
| AMICUS THERAPEUTICS INC | 26 | Q2 2022 | 4.3% |
| PFIZER INC | 25 | Q3 2023 | 9.2% |
| SAREPTA THERAPEUTICS INC | 25 | Q3 2023 | 3.2% |
| JOHNSON & JOHNSON | 24 | Q3 2023 | 8.0% |
| UNIQURE NV | 23 | Q3 2023 | 1.2% |
| SYNDAX PHARMACEUTICALS INC | 22 | Q3 2023 | 3.9% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyclacel Pharmaceuticals, Inc. | February 06, 2023 | 250,000 | 2.0% |
| Altimmune, Inc. | February 14, 2022 | 1,244,241 | 3.1% |
| Allot Ltd. | February 16, 2021 | 1,129,054 | 3.2% |
| Larimar Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Neos Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Orgenesis Inc. | February 16, 2021 | 525,216 | 0.0% |
| Sio Gene Therapies Inc. | February 16, 2021 | ? | ? |
| X4 Pharmaceuticals, Inc | February 16, 2021 | 250,000 | 0.0% |
| Axovant Gene Therapies Ltd. | February 25, 2020 | 2,931,017 | 8.0% |
| Axovant Gene Therapies Ltd. | February 11, 2020 | 398,540 | 1.8% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-08 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-10 |
| SC 13G | 2023-08-30 |
View SPHERA FUNDS MANAGEMENT LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.